Table 2. Relationship between acetyl-histones 3 and 4 expression and the clinicopathological features of glioma.
Clinicopathological features | acetyl-histone 3 expression | acetyl-histone 4 expression | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | - | + | ++ | +++ | PR(%) | p | n | - | + | ++ | +++ | PR(%) | p | |
Sex | ||||||||||||||
Male | 111 | 9 | 14 | 31 | 57 | 91.9 | 0.229 | 111 | 13 | 19 | 33 | 46 | 88.3 | 0.014* |
Female | 75 | 0 | 8 | 25 | 42 | 100 | 76 | 1 | 10 | 23 | 42 | 98.7 | ||
Age (years) | ||||||||||||||
<44 | 83 | 4 | 8 | 25 | 46 | 95.2 | 0.482 | 85 | 7 | 18 | 30 | 30 | 91.8 | 0.004* |
≥44 | 102 | 5 | 14 | 31 | 52 | 95.1 | 101 | 7 | 11 | 25 | 58 | 93.1 | ||
Pathological grading | ||||||||||||||
I-II | 81 | 3 | 7 | 31 | 40 | 96.3 | 0.260 | 84 | 7 | 14 | 34 | 29 | 91.7 | 0.112 |
III-IV | 51 | 5 | 10 | 12 | 24 | 90.2 | 47 | 6 | 6 | 8 | 27 | 87.2 | ||
Pathological classification | ||||||||||||||
astrocytoma | 102 | 8 | 12 | 33 | 49 | 92.2 | 0.384 | 103 | 11 | 20 | 33 | 39 | 89.3 | 0.004* |
anaplastic astrocytoma |
32 | 1 | 4 | 7 | 20 | 96.9 | 31 | 2 | 3 | 7 | 19 | 93.5 | ||
glioblastoma | 26 | 0 | 5 | 8 | 13 | 100 | 25 | 0 | 3 | 7 | 15 | 100 |
p< 0.05; PR, positive rate